Microcap Ledger Lifeward Ltd. $LFWD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Hudson, MA
- Fiscal year end
- December 31
- Shares outstanding
- 2,832,016 [10-Q 2026-08-14]
What the company doesAI summary of filing
Lifeward Ltd. develops and sells wearable robotic exoskeletons and anti-gravity exercise systems for rehabilitation and mobility assistance. The company's primary products are the ReWalk Personal Exoskeleton for spinal cord injury patients, the AlterG Anti-Gravity system for rehabilitation clinics and sports medicine practices, the MyoCycle FES cycle, and the ReStore exo-suit for stroke rehabilitation (currently a limited portion of business). The company generates revenue from product sales, related consumables, services, and extended warranties, and it operates as a revenue-generating company with FDA and CE mark clearances for its marketed products. Lifeward acquired AlterG in August 2023 and has since consolidated manufacturing operations; the company holds $2.2 million in cash as of December 31, 2025, and requires additional capital to fund ongoing operations and execute its business strategy. [10-K 2026-03-18]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $10.55M | −$22.31M | −$9.68M | $9.45M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | $22.03M | −$19.90M | −$16.83M | $2.17M | [10-K 2026-03-18] |
| FY ended Dec 2024 | $25.66M | −$28.90M | −$21.72M | $6.75M | [10-K 2026-03-18] |
- Quarterly cash burn
- −$4.84M
- Cash runway Estimate
- ~5.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-07 | 8,808,143 | [10-Q 2024-11-12] |
| 2025-03-06 | 10,630,281 | [10-K 2025-03-07] |
| 2025-05-13 | 11,007,592 | [10-Q 2025-05-15] |
| 2025-08-12 | 15,704,622 | [10-Q 2025-08-14] |
| 2025-11-12 | 17,732,137 | [10-Q 2025-11-14] |
| 2026-03-17 | 1,528,222 | [10-K 2026-03-18] |
| 2026-05-18 | 2,814,409 | [10-Q 2026-05-20] |
| 2026-08-12 | 2,832,016 | [10-Q 2026-08-14] |
- Shelf registration
- S-3 filed 2026-08-03; declared effective 2026-08-10 [S-3 2026-08-03]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-03-20. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-03-20 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-03-20] |
| 2025-08-08 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-08] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-20 | Gabay Avraham | grant | 13,643 | — | [4 2026-08-24] |
| 2026-08-14 | Zamir Haggai | grant | 6,711 | — | [4 2026-09-10] |
| 2026-08-14 | Greenwald Yonason | grant | 6,711 | — | [4 2026-08-28] |
| 2026-05-01 | Rose Keith Dale | grant | 15,000 | — | [4 2026-05-20] |
| 2026-03-25 | Sigsbee William Mark | grant | 11,485 | — | [4 2026-04-13] |
| 2026-03-25 | Rozenbaum Moshe H | grant | 11,485 | — | [4 2026-04-13] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-08 | 8-K | Director or officer change |
| 2026-10-01 | 8-K | Director or officer change |
| 2026-09-25 | DEF 14A | Proxy statement |
| 2026-09-15 | PRE 14A | Proxy statement |
| 2026-09-08 | 8-K | Regulation FD disclosure |
| 2026-08-31 | 8-K | Director or officer change |
| 2026-08-20 | 8-K | Director or officer change |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-08-14 | 8-K | Results of operations; Director or officer change |
| 2026-08-03 | S-3 | Registration statement |
| 2026-07-07 | 8-K | Material agreement entered; New financial obligation; Unregistered sale of equity |
| 2026-05-20 | 10-Q | Quarterly report |
Alerts for $LFWD
Email me when Lifeward Ltd. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.